Swiss All Share Index

Swiss All Share Index handeln
18.791,14 PKT +82,62 PKT +0,44 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

ISIN CH0009111011


Analysen zu Swiss All Share Index-Werten

Datum Rating Analyst
18.01.22 Givaudan Neutral UBS AG
18.01.22 Clariant Neutral UBS AG
18.01.22 Holcim Hold Jefferies & Company Inc.
18.01.22 ams-OSRAM Underweight Barclays Capital
18.01.22 Nestlé Buy UBS AG
18.01.22 UBS Overweight Barclays Capital
18.01.22 Richemont Overweight Morgan Stanley
18.01.22 Givaudan Neutral JP Morgan Chase & Co.
18.01.22 Nestlé Overweight JP Morgan Chase & Co.
18.01.22 Holcim Neutral JP Morgan Chase & Co.
17.01.22 Swiss Re Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
17.01.22 Nestlé Overweight Barclays Capital
17.01.22 Holcim Overweight Morgan Stanley
17.01.22 UBS Underweight JP Morgan Chase & Co.
17.01.22 Roche Buy Deutsche Bank AG
17.01.22 Clariant Neutral JP Morgan Chase & Co.
17.01.22 Zurich Insurance Buy HSBC
14.01.22 Nestlé Overweight Barclays Capital
14.01.22 Nestlé Buy Goldman Sachs Group Inc.
14.01.22 Novartis Equal-weight Morgan Stanley
13.01.22 ams-OSRAM Neutral Credit Suisse Group
13.01.22 ABB (Asea Brown Boveri) Equal Weight Barclays Capital
13.01.22 Roche Neutral JP Morgan Chase & Co.
12.01.22 DocMorris Add Baader Bank
12.01.22 ABB (Asea Brown Boveri) Hold Deutsche Bank AG
12.01.22 Novartis Underweight JP Morgan Chase & Co.
12.01.22 Holcim Buy UBS AG
11.01.22 UBS Sector Perform RBC Capital Markets
11.01.22 Richemont Overweight Barclays Capital
11.01.22 Roche Buy Deutsche Bank AG
11.01.22 UBS Overweight JP Morgan Chase & Co.
11.01.22 ABB (Asea Brown Boveri) Neutral JP Morgan Chase & Co.
11.01.22 ams-OSRAM Overweight JP Morgan Chase & Co.
11.01.22 Givaudan Neutral Goldman Sachs Group Inc.
10.01.22 Richemont Outperform RBC Capital Markets
10.01.22 UBS Overweight JP Morgan Chase & Co.
07.01.22 DocMorris Buy Jefferies & Company Inc.
07.01.22 UBS Neutral UBS AG
07.01.22 Novartis Neutral UBS AG
07.01.22 UBS Outperform RBC Capital Markets